Obbligazioni TEV
Di seguito è riportato l'elenco delle obbligazioni societarie Teva Pharmaceutical Industries Limited Sponsored ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA6082389Teva Pharmaceutical Finance Netherlands IV BV 5.75% 01-DEC-2030 | — | 3,58 M | 102,25% | 5,75% | 2030-12-01 | 700 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA5295244Teva Pharmaceutical Finance Netherlands III BV 4.75% 09-MAY-2027 | — | 200 K | 99,52% | 4,75% | 2027-05-09 | 649,12 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | — | 300 K | 109,38% | 7,88% | 2029-09-15 | 397,68 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA6082388Teva Pharmaceutical Finance Netherlands III BV 6.0% 01-DEC-2032 | — | 1 M | 103,00% | 6,00% | 2032-12-01 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5295245Teva Pharmaceutical Finance Netherlands III BV 5.125% 09-MAY-2029 | — | 222 K | 101,49% | 5,13% | 2029-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | — | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608604Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | — | 100 K | 103,99% | 6,75% | 2028-03-01 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | — | 1,3 M | 113,75% | 8,13% | 2031-09-15 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | — | 10 K | 85,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1.000,00 USD | 1.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| UUS88163VAD1Teva Pharmaceutical Finance Co. LLC 6.15% 01-FEB-2036 | — | 0 | 102,65% | 6,15% | 2036-02-01 | 789,43 M USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| XXS143974936Teva Pharmaceutical Finance Netherlands II BV 1.625% 15-OCT-2028 | — | 0 | 95,16% | 1,63% | 2028-10-15 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| TTFABTeva Pharmaceutical Finance Netherlands III BV 3.15% 01-OCT-2026 | — | 0 | 97,59% | 3,15% | 2026-10-01 | 1,8 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFACTeva Pharmaceutical Finance Netherlands III BV 4.1% 01-OCT-2046 | — | 0 | 72,45% | 4,10% | 2046-10-01 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS121104407Teva Pharmaceutical Finance Netherlands II BV 1.875% 31-MAR-2027 | — | 0 | 97,98% | 1,88% | 2027-03-31 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS308179796Teva Pharmaceutical Finance Netherlands II BV 4.125% 01-JUN-2031 | — | 0 | 100,63% | 4,13% | 2031-06-01 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709Teva Pharmaceutical Finance Netherlands II BV 3.75% 09-MAY-2027 | — | 0 | 100,73% | 3,75% | 2027-05-09 | 1,1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717Teva Pharmaceutical Finance Netherlands II BV 4.375% 09-MAY-2030 | — | 0 | 102,27% | 4,38% | 2030-05-09 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280419Teva Pharmaceutical Finance Netherlands II BV 7.875% 15-SEP-2031 | — | 0 | 119,93% | 7,88% | 2031-09-15 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443Teva Pharmaceutical Finance Netherlands II BV 7.375% 15-SEP-2029 | — | 0 | 112,97% | 7,38% | 2029-09-15 | 662,58 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |